肿瘤学的进步,尤其是在精准肿瘤学时代,导致癌症治疗的范式转变。的确,创新技术,比如人工智能,正在为加强诊断铺平道路,预防,和个性化治疗以及新的药物发现。尽管取得了巨大的进步,耐药癌症的出现限制了我们前进的速度和程度。通过结合他们对基本生物学机制和人工智能和数据科学等技术进步的理解,癌症研究人员现在开始解决这个问题。一起,这将彻底改变癌症治疗,通过加强可能有助于癌症预防的分子干预,告知临床决策,并加速新型治疗药物的开发。这里,我们将讨论人工智能和精准肿瘤学的进展和方法,在第59届爱尔兰癌症研究协会年度会议上发表。
Advancements in oncology, especially with the era of precision oncology, is resulting in a paradigm shift in cancer care. Indeed, innovative technologies, such as artificial intelligence, are paving the way towards enhanced diagnosis, prevention, and personalised treatments as well as novel drug discoveries. Despite excellent progress, the emergence of resistant cancers has curtailed both the pace and extent to which we can advance. By combining both their understanding of the fundamental biological mechanisms and technological advancements such as artificial intelligence and data science, cancer researchers are now beginning to address this. Together, this will revolutionise cancer care, by enhancing molecular interventions that may aid cancer prevention, inform clinical decision making, and accelerate the development of novel therapeutic drugs. Here, we will discuss the advances and approaches in both artificial intelligence and precision oncology, presented at the 59th Irish Association for Cancer Research annual conference.